NextCure

Home » NextCure

IPO

NextCure

We are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function.

Symbol

NXTC

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Effective Date
May 9, 2019

Underwriters
MORGAN STANLEY & CO. LLC, PIPER JAFFRAY & CO.

To view the prospectus for NextCure IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253